Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the process of cataract development and its prevalence in both older and younger populations.
Occurring naturally over time, cataracts can develop in both older and younger populations, particularly those with diabetes or prior eye injuries, said Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision.
Transcript
Can you discuss the prevalence of cataracts among adults in the United States?
Cataracts, as you probably know, are a natural clouding of the lens of the eye. It happens naturally as we age, and it's estimated that by age 75, approximately half of all Americans have cataracts. And cataracts continue to develop as we get older.
There are some reasons that a cataract can develop at an earlier age. For example, if patients are on certain medications, if they're diabetic, if they have a family history of cataracts, or sometimes if they've had significant injuries around the eyes. There are multiple reasons that we look for cataracts at an earlier age, as well.
What trends are you seeing in the development of cataracts?
Certainly, as we all have greater visual needs, we are finding that the age for cataract surgery is occurring at an earlier age in life, because ultimately cataracts decrease vision. So, if we're doing more visually, then we notice that earlier, but the trends in general are still similar.
It's related to those medical conditions or family history at an early age, but otherwise, it's primarily related to age. And it's thought that it’s that natural process of the lens becoming more dense and cloudy, which is really what a cataract is.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More